Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

593
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
593
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

871
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
871
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph.

BMC bioinformatics·2026
Same author

TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies.

Molecular cancer therapeutics·2026
Same author

Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Cancer discovery·2026
Same author

Systems biology graphical notation: process description language level 1 version 2.1.

Journal of integrative bioinformatics·2026
Same author

textToKnowledgeGraph: generation of molecular interaction knowledge graphs using large language models for exploration in Cytoscape.

Bioinformatics (Oxford, England)·2026
Same author

A prognostic matrix gene expression signature defines functional glioblastoma phenotypes and niches.

Communications biology·2026

Related Experiment Video

Updated: Aug 1, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

483

Mapping the functional interactions at the tumor-immune checkpoint interface.

Behnaz Bozorgui1, Elisabeth K Kong2, Augustin Luna3,4

  • 1Department of Bioinformatics and Computational Biology, UT MD Anderson Cancer Center, Houston, TX, 77030, USA. bbozorgui@mdanderson.org.

Communications Biology
|April 27, 2023
PubMed
Summary
This summary is machine-generated.

We developed ImogiMap, a novel framework to map tumor-immune checkpoint interactions. This tool identifies key interactions influencing cancer immune evasion and immunotherapy response, aiding in discovering new therapeutic targets.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.7K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.6K

Related Experiment Videos

Last Updated: Aug 1, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

483
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.7K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.6K

Area of Science:

  • Oncology
  • Immunology
  • Bioinformatics

Background:

  • Tumor-intrinsic processes and immune checkpoints critically influence cancer immune evasion and immunotherapy outcomes.
  • The complex tumor-immune microenvironment poses challenges in identifying functional interactions.
  • Understanding these interactions is crucial for developing effective cancer immunotherapies.

Purpose of the Study:

  • To develop a statistical framework, ImogiMap, for quantifying and validating tumor-immune checkpoint interactions.
  • To create a catalog of tumor-immune checkpoint interaction maps associated with immune phenotypes.
  • To provide an open-source tool for discovering novel tumor-immune interactions and immunotherapy targets.

Main Methods:

  • Utilized a statistical analysis framework, ImogiMap, to quantify tumor-immune checkpoint interactions.
  • Validated interactions based on co-associations with immune-associated phenotypes.
  • Applied ImogiMap to analyze interactions related to interferon gamma (IFNγ) expression.

Main Results:

  • Generated a catalog of tumor-immune checkpoint interaction maps for various immune phenotypes.
  • Recapitulated known interactions, such as SERPINB9 with immune checkpoints and IFNγ expression.
  • Identified significant associations between CD86-CD70 and CD274-CD70 interactions with IFNγ expression in specific cancer types.

Conclusions:

  • ImogiMap effectively identifies and validates functional tumor-immune checkpoint interactions.
  • The framework highlights specific interactions (e.g., CD86-CD70, CD274-CD70) relevant to IFNγ expression in cancers.
  • The open-source ImogiMap software facilitates future research into tumor-immune interactions and immunotherapy targets.